Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

A genetic mutation in horses that would typically halt protein production has become a molecular asset. Researchers at Johns ...

For generations, a tiny piece of DNA has mastered the art of inheritance by hijacking the yeast cell’s division machinery, ...

Lariocidin hits drug-resistant bacteria where others fail — by hijacking the ribosome at a new site, bypassing defences, and opening the door to a new generation of antibiotics. Lariocidin ...

Multi-epitope immunopurifications of huntingtin (HTT) from vulnerable brain regions of Huntington’s disease (HD) models ...

Because chemogenetic control relies on DREADD expression levels, understanding and quantifying the temporal dynamics of their expression is crucial for planning long-term experiments in monkeys. In ...

Dr. Aubrey de Grey discusses his Robust Mouse Rejuvenation (RMR) studies at the LEV Foundation. He believes that three more RMR (Robust Mouse Rejuvenation) studies of combination therapy will get us ...